Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
boston blog main
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
lasmiditan
life sciences
migraine research foundation
national blog main
raleigh-durham blog main
raleigh-durham top stories
teva pharmaceutical
triptans
alder biopharmaceutical
allergan
alprazolam
american academy of neurology
atogepant
basil harris
biohaven
bob azelby
boston top stories
botox
boulder/denver blog main
boulder/denver top stories
brian abrahams
business
calcitonin gene-related peptide
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
detroit blog main
detroit top stories
drug enforcement administration
drugs
dxter
eptinezumab
What
decades
3
×
won
approval
drug
fda
migraine
new
year
acute
addresses
ago
arguments
basil
big
bones
carried
causes
class
commercialized
companies
competitors
condition
created
devices
dr
drugs
eli
fictional
final
friday
frontier
giant
giving
good
harris
here’s
job
journey
lasmiditan
lilly
Language
unset
Current search:
won���t
×
decades
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@venturebeat.com
7 years ago
Here’s the Star Trek Tricorder that won the $3 million Qualcomm Xprize